How ecstasy and psilocybin are shaking up psychiatry

This publication has 8 references indexed in Scilit:

• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
  JAMA Psychiatry, 2021
• Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
  Nature Reviews Neuroscience, 2020
• Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
  ACS Pharmacology & Translational Science, 2020
• Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
  Journal of Psychopharmacology, 2020
• Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
  Psychopharmacology, 2017
• LSD‐induced entropic brain activity predicts subsequent personality change
  Human Brain Mapping, 2016
• Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice
  Neuropharmacology, 2013
• Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis
  Neuropsychopharmacology, 1997